This virtual conference will provide expert perspectives on current challenges, new opportunities, and future directions in the management of rare hematologic malignancies. Attendees will be able to apply emerging data in treatment selection and supportive care for patients with acute lymphoblastic leukemia, Hodgkin lymphoma, mantle cell lymphoma, myelodysplastic syndromes, and Waldenstrom macroglobulinemia. Register today!
This two-part live webinar series led by Sarah A. Holstein, MD, PhD, and Ashley E. Rosko, MD, will explore expert perspectives on practice-changing developments in the management of multiple myeloma and will also include updates from the 2021 American Society of Hematology (ASH) Annual Meeting & Exposition.
Part 2 will familiarize practitioners with indications of multiple myeloma progression and timing of therapy, highlight practice-changing trials in the early and late relapse settings, and discuss how approaches to relapsed/refractory multiple myeloma are changing based on emerging data. Regsiter now.